AEOLUS PHARMACEUTICALS, INC.
company.status.inactiveCIK 1261734fmd_0F3MSG22QFSWT33916VJMQJ9AHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Jun 30, 2017, 30 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | 5 | 7 | 4 | 10 | 3 | – |
| Realized investment gains (losses) | 0 | 0 | – | – | – | – | – |
| Research and development | 2 | 5 | 6 | 3 | 7 | 4 | 3 |
| Operating income | (4) | (4) | (2) | (3) | (0) | (3) | (3) |
| Interest expense | (1) | 0 | 0 | – | 0 | 0 | 0 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (26) | 0 | 2 | (3) | (0) | (3) | (4) |
| Net income to common shareholders | – | 0 | 1 | (3) | (0) | (3) | (6) |